These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Screening for congenital adrenal hyperplasia: distribution of 17 alpha-hydroxyprogesterone concentrations in neonatal blood spot specimens. Thompson R, Seargeant L, Winter JS. J Pediatr; 1989 Mar; 114(3):400-4. PubMed ID: 2784166 [Abstract] [Full Text] [Related]
3. [Neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. 1. Enzyme immunoassay of dried blood 17 alpha-hydroxyprogesterone and its application to neonatal screening for congenital adrenal hyperplasia]. Fukushi M, Arai O, Mizushima Y, Takasugi N, Fujieda K, Matsuura N. Nihon Naibunpi Gakkai Zasshi; 1986 Jun 20; 62(6):683-96. PubMed ID: 3530828 [Abstract] [Full Text] [Related]
4. Radioimmunoassay of blood-spot 17 alpha-hydroxyprogesterone in the management of congenital adrenal hyperplasia. Robinson JA, Dyas J, Hughes IA, Riad-Fahmy D. Ann Clin Biochem; 1987 Jan 20; 24 ( Pt 1)():58-65. PubMed ID: 3827186 [Abstract] [Full Text] [Related]
7. "Dot-17 alpha-hydroxyprogesterone" radioimmunoassay for identification of congenital adrenal hyperplasia in young infants. Sólyom J, Hervei S, Marossy P, Sólyom E, Babosa M, Szombathy G. Acta Paediatr Scand; 1981 Nov 20; 70(6):913-7. PubMed ID: 7324946 [Abstract] [Full Text] [Related]
8. Bloodspot 17 alpha-hydroxyprogesterone radioimmunoassay for diagnosis of congenital adrenal hyperplasia and home monitoring of corticosteroid replacement therapy. Riordan FA, Wood PJ, Wakelin K, Betts P, Clayton BE. Lancet; 1984 Mar 31; 1(8379):708-11. PubMed ID: 6143043 [Abstract] [Full Text] [Related]
17. Monitoring congenital adrenal hyperplasia using blood spot 17-hydroxyprogesterone assay. Santos CM, Abad LR, Cua SC, Domingo CF. Southeast Asian J Trop Med Public Health; 2003 Jun 31; 34 Suppl 3():174-8. PubMed ID: 15906729 [Abstract] [Full Text] [Related]
18. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants. Nordenström A, Wedell A, Hagenfeldt L, Marcus C, Larsson A. Pediatrics; 2001 Oct 31; 108(4):E68. PubMed ID: 11581476 [Abstract] [Full Text] [Related]
19. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values. Fingerhut R. Steroids; 2009 Aug 31; 74(8):662-5. PubMed ID: 19463687 [Abstract] [Full Text] [Related]